Gallstones: Prevention, Diagnosis, and Treatment

Abstract

Gallstones are common and affect up to 20% of the general adult population and >20% of them will develop symptoms or complications of cholelithiasis. The high risk of gallbladder stone formation can be reduced by ursodeoxycholic acid in the case of significant weight reduction resulting from diet or bariatric surgery. Laparoscopic cholecystectomy is indicated for symptomatic gallstones, as the risk of recurrence or complications increases over the course of the disease. Biliary colic is treated with nonsteroidal anti-inflammatory drugs and spasmolytics; opioids can also be used in cases of severe acute pain. Acute cholecystitis represents a common complication of gallbladder stones and a cholecystectomy should be performed early electively, i.e., within 24 hours of admission to hospital. Symptomatic bile duct stones are primarily treated endoscopically. Immediate anti-infective therapy is mandatory in acute cholangitis. Although knowledge on the genetics and pathophysiology of gallstones has increased, current treatment algorithms remain predominantly invasive, based on interventional endoscopy and surgery. Future efforts should focus on novel strategies to prevent the development of gallstones.

Keywords

cholelithiasis - cholecystectomy - endoscopic retrograde cholangiography - genetic risk factors - ursodeoxycholic acid

Publication History

Accepted Manuscript online:
02 August 2024

Article published online:
02 September 2024

• References

• 1 Lammert F, Acalovschi M, Ercolani G. et al. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol 2016; 65 (01) 146-181
• 2 Lammert F, Gurusamy K, Ko CW. et al. Gallstones. Nat Rev Dis Primers 2016; 2: 16024
• 3 Gutt C, Schläfer S, Lammert F. The treatment of gallstone disease. Dtsch Arztebl Int 2020; 117 (09) 148-158
• 4 Hu H, Shao W, Liu Q. et al. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion. Nat Commun 2022; 13 (01) 252
• 5 Wang X, Yu W, Jiang G. et al. Global epidemiology of gallstones in the 21st century: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2024; 22 (08) 1586-1595
• 6 Stokes CS, Gluud LL, Casper M, Lammert F. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2014; 12 (07) 1090-1100.e2 , quiz e61
• 7 Haal S, Guman MSS, Boerlage TCC. et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Lancet Gastroenterol Hepatol 2021; 6 (12) 993-1001
• 8 Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 1995; 122 (12) 899-905
• 9 Gutt C, Jenssen C, Barreiros AP. et al. Aktualisierte S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) zur Prävention, Diagnostik und Behandlung von Gallensteinen. Z Gastroenterol 2018; 56 (08) 912-966
• 10 He L, Wang J, Ping F. et al. Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2022; 182 (05) 513-519
• 11 Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001; 120 (06) 1459-1467
• 12 Lammert F, Wang DQ, Hillebrandt S. et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2^-/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology 2004; 39 (01) 117-128
• 13 De Vree JM, Jacquemin E, Sturm E. et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998; 95 (01) 282-287
• 14 Biyoukar M, Corpechot C, El Mouhadi S. et al. ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome. JHEP Rep Innov Hepatol 2022; 4 (11) 100590
• 15 Wirth J, Joshi AD, Song M. et al. A healthy lifestyle pattern and the risk of symptomatic gallstone disease: results from 2 prospective cohort studies. Am J Clin Nutr 2020; 112 (03) 586-594
• 16 Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006; 20 (06) 981-996
• 17 Shea JA, Berlin JA, Escarce JJ. et al. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med 1994; 154 (22) 2573-2581
• 18 Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307 (13) 798-800
• 19 Friedman GD, Raviola CA, Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989; 42 (02) 127-136
• 20 Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D. Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 1983; 99 (02) 199-204
• 21 Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: the GREPCO experience. Hepatology 1995; 21 (03) 655-660
• 22 Festi D, Sottili S, Colecchia A. et al. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 1999; 30 (04) 839-846
• 23 Thistle JL, Cleary PA, Lachin JM, Tyor MP, Hersh T. The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med 1984; 101 (02) 171-175
• 24 Besselink MG, Venneman NG, Go PM. et al. Is complicated gallstone disease preceded by biliary colic?. J Gastrointest Surg 2009; 13 (02) 312-317
• 25 Jørgensen T. Abdominal symptoms and gallstone disease: an epidemiological investigation. Hepatology 1989; 9 (06) 856-860
• 26 Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM. Symptomatic and silent gall stones in the community. Gut 1991; 32 (03) 316-320
• 27 Venneman NG, Renooij W, Rehfeld JF. et al. Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis. Hepatology 2005; 41 (04) 738-746
• 28 Bagepally BS, Haridoss M, Sasidharan A, Jagadeesh KV, Oswal NK. Systematic review and meta-analysis of gallstone disease treatment outcomes in early cholecystectomy versus conservative management/delayed cholecystectomy. BMJ Open Gastroenterol 2021; 8 (01) e000675
• 29 Van Dijk AH, Wennmacker SZ, de Reuver PR. et al. Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-inferiority trial. Lancet 2019; 393 (10188): 2322-2330
• 30 Gurusamy KS, Vaughan J, Rossi M, Davidson BR. Fewer-than-four ports versus four ports for laparoscopic cholecystectomy. Cochrane Database Syst Rev 2014; 2014 (02) CD007109
• 31 Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 2001; 129 (06) 699-703
• 32 Chazouilleres O, Beuers U, Bergquist A. et al. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol 2022; 77 (03) 761-806
• 33 Bernini M, Bencini L, Sacchetti R. et al. The Cholegas Study: safety of prophylactic cholecystectomy during gastrectomy for cancer: preliminary results of a multicentric randomized clinical trial. Gastric Cancer 2013; 16 (03) 370-376
• 34 Tsirline VB, Keilani ZM, El Djouzi S. et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery?. Surg Obes Relat Dis 2014; 10 (02) 313-321
• 35 Sackmann M. Behandlung der biliären Kolik. Dtsch Med Wochenschr 1998; 123 (31-32): 945-947
• 36 Kumar A, Deed JS, Bhasin B, Kumar A, Thomas S. Comparison of the effect of diclofenac with hyoscine-N-butylbromide in the symptomatic treatment of acute biliary colic. ANZ J Surg 2004; 74 (07) 573-576
• 37 Akriviadis EA, Hatzigavriel M, Kapnias D, Kirimlidis J, Markantas A, Garyfallos A. Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology 1997; 113 (01) 225-231
• 38 Lammert F. Gallstones: the thing in itself. Clin Liver Dis (Hoboken) 2022; 20 (Suppl. 01) 57-72
• 39 May GR, Sutherland LR, Shaffer EA. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther 1993; 7 (02) 139-148
• 40 Venneman NG, Besselink MG, Keulemans YC. et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 2006; 43 (06) 1276-1283
• 41 Ralls PW, Colletti PM, Lapin SA. et al. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. Radiology 1985; 155 (03) 767-771
• 42 Gutt CN, Encke J, Köninger J. et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg 2013; 258 (03) 385-393
• 43 Hantouli MN, Droullard DJ, Nash MG. et al. Operative vs nonoperative management of acute cholecystitis during the different trimesters of pregnancy. JAMA Surg 2024; 159 (01) 28-34
• 44 Loozen CS, van Santvoort HC, van Duijvendijk P. et al. Laparoscopic cholecystectomy versus percutaneous catheter drainage for acute cholecystitis in high risk patients (CHOCOLATE): multicentre randomised clinical trial. BMJ 2018; 363: k3965
• 45 Mayumi T, Okamoto K, Takada T. et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25 (01) 96-100
• 46 Dollhopf M, Larghi A, Will U. et al. EUS-guided gallbladder drainage in patients with acute cholecystitis and high surgical risk using an electrocautery-enhanced lumen-apposing metal stent device. Gastrointest Endosc 2017; 86 (04) 636-643
• 47 Luk SW, Irani S, Krishnamoorthi R, Wong Lau JY, Wai Ng EK, Teoh AY. Endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for high risk surgical patients with acute cholecystitis: a systematic review and meta-analysis. Endoscopy 2019; 51 (08) 722-732
• 48 Teoh AYB, Kitano M, Itoi T. et al. Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superiority trial (DRAC 1). Gut 2020; 69 (06) 1085-1091
• 49 Elshaer M, Gravante G, Thomas K, Sorge R, Al-Hamali S, Ebdewi H. Subtotal cholecystectomy for “difficult gallbladders”: systematic review and meta-analysis. JAMA Surg 2015; 150 (02) 159-168
• 50 Anderson JE, Inui T, Talamini MA, Chang DC. Cholecystostomy offers no survival benefit in patients with acute acalculous cholecystitis and severe sepsis and shock. J Surg Res 2014; 190 (02) 517-521
• 51 Maringhini A, Moreau JA, Melton III LJ, Hench VS, Zinsmeister AR, DiMagno EP. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med 1987; 107 (01) 30-35
• 52 Sherman S, Hawes RH, Lehman GA. Management of bile duct stones. Semin Liver Dis 1990; 10 (03) 205-221
• 53 Gurusamy KS, Giljaca V, Takwoingi Y. et al. Ultrasound versus liver function tests for diagnosis of common bile duct stones. Cochrane Database Syst Rev 2015; 2015 (02) CD011548
• 54 Giljaca V, Gurusamy KS, Takwoingi Y. et al. Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones. Cochrane Database Syst Rev 2015; 2015 (02) CD011549
• 55 Meeralam Y, Al-Shammari K, Yaghoobi M. Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studies. Gastrointest Endosc 2017; 86 (06) 986-993
• 56 Ko CW, Lee SP. Epidemiology and natural history of common bile duct stones and prediction of disease. Gastrointest Endosc 2002; 56 (6, Suppl): S165-S169
• 57 Möller M, Gustafsson U, Rasmussen F, Persson G, Thorell A. Natural course vs interventions to clear common bile duct stones: data from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surg 2014; 149 (10) 1008-1013
• 58 Reinders JS, Goud A, Timmer R. et al. Early laparoscopic cholecystectomy improves outcomes after endoscopic sphincterotomy for choledochocystolithiasis. Gastroenterology 2010; 138 (07) 2315-2320
• 59 Boerma D, Rauws EA, Keulemans YC. et al. Wait-and-see policy or laparoscopic cholecystectomy after endoscopic sphincterotomy for bile-duct stones: a randomised trial. Lancet 2002; 360 (9335): 761-765
• 60 Weinberg BM, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev 2006; 2006 (04) CD004890
• 61 Du L, Cen M, Zheng X, Luo L, Siddiqui A, Kim JJ. Timing of performing endoscopic retrograde cholangiopancreatography and inpatient mortality in acute cholangitis: a systematic review and meta-analysis. Clin Transl Gastroenterol 2020; 11 (03) e00158
• 62 Fusaroli P, Jenssen C, Hocke M. et al. European Federation of Societies for Ultrasound in Medicine and Biology, Guidelines on Interventional Ultrasound (INVUS), Part V. Ultraschall Med 2016; 37: E77-E99
• 63 Sharaiha RZ, Khan MA, Kamal F. et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc 2017; 85 (05) 904-914
• 64 Lai EC, Mok FP, Tan ES. et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992; 326 (24) 1582-1586
• 65 Dasari BV, Tan CJ, Gurusamy KS. et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev 2013; (12) CD003327
• 66 Schepers NJ, Hallensleben NDL, Besselink MG. et al. Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial. Lancet 2020; 396 (10245): 167-176
• 67 Hallensleben ND, Stassen PMC, Schepers NJ. et al. Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study. Gut 2023; 72 (08) 1534-1542
• 68 Da Costa DW, Bouwense SA, Schepers NJ. et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet 2015; 386 (10000): 1261-1268
• 69 Nealon WH, Bawduniak J, Walser EM. Appropriate timing of cholecystectomy in patients who present with moderate to severe gallstone-associated acute pancreatitis with peripancreatic fluid collections. Ann Surg 2004; 239 (06) 741-749 , discussion 749–751
• 70 Hallensleben ND, Timmerhuis HC, Hollemans RA. et al. Dutch Pancreatitis Study Group. Optimal timing of cholecystectomy after necrotising biliary pancreatitis. Gut 2022; 71 (05) 974-982
• 71 Di Martino M, Ielpo B, Pata F. et al. Timing of cholecystectomy after moderate and severe acute biliary pancreatitis. JAMA Surg 2023; 158 (10) e233660
• 72 Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326 (09) 589-593
• 73 Nakayama F. Intrahepatic calculi: a special problem in East Asia. World J Surg 1982; 6 (06) 802-804
• 74 Portincasa P, Di Ciaula A, Bonfrate L, Stella A, Garruti G, Lamont JT. Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations. Intern Emerg Med 2023; 18 (07) 1897-1918
• 75 Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005; 2 (09) 423-433